A
Arecor Therapeutics PLC
LSE:AREC
Arecor Therapeutics PLC
LSE:AREC
Price:
131 GBX
Market Closed
Updated:
May 19, 2024
Arecor Therapeutics PLC
Other Operating Expenses
|
Arecor Therapeutics PLC
Other Operating Expenses Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Arecor Therapeutics PLC
LSE:AREC
|
Other Operating Expenses
£1.1m
|
CAGR 3-Years
49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Other Operating Expenses
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Other Operating Expenses
-£606.7m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
See Also
What is Arecor Therapeutics PLC's Other Operating Expenses?
Other Operating Expenses
1.1m
GBP
1.1m
GBP
Based on the financial report for Dec 31, 2022, Arecor Therapeutics PLC's Other Operating Expenses amounts to 1.1m GBP.
What is Arecor Therapeutics PLC's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 3Y
49%
49%
Over the last year, the Other Operating Expenses growth was 77%. The average annual Other Operating Expenses growth rates for Arecor Therapeutics PLC have been 49% over the past three years .
You don't have any saved screeners yet
